<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4601831</article-id><article-id pub-id-type="publisher-id">1470-7330-15-S1-O28</article-id><article-id pub-id-type="doi">10.1186/1470-7330-15-S1-O28</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Hepatic lesions</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Schima</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Jhaveri</surname><given-names>Kartik S</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Diagnostic and Interventional Radiology, KH G&#x000f6;ttlicher Heiland, KH der Barmherzigen Schwestern and Sankt Josef-Krankenhaus, Vinzenzgruppe, Vienna, Austria</aff><aff id="I2"><label>2</label>Abdominal Imaging, University Health Network, Mt. Sinai and WCH, Toronto, Canada</aff><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>2</day><month>10</month><year>2015</year></pub-date><volume>15</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens Healthcare GmbH.</named-content></supplement><fpage>O28</fpage><lpage>O28</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Schima and Jhaveri</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Schima and Jhaveri</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/15/S1/O28"/><conference><conf-date>5-7 October 2015</conf-date><conf-name>International Cancer Imaging Society Meeting and 15th Annual Teaching Course (ICIS 2015)</conf-name><conf-loc>London, UK</conf-loc></conference></article-meta></front><body><sec><title/><p>The liver presents with a variety of lesions for evaluation and appropriate triage with imaging. Ultrasound, MDCT and particularly MRI play a significant role in this objective. In patients without a known malignancy the vast majority of non-cystic lesions are benign (hemangioma, FNH, adenoma, focal fat, etc.), while a few are malignant. However, common benign hepatic lesions may pose a dilemma, if their imaging features are atypical. Although patients with a known malignancy are more likely to have a diagnosis of metastasis for a liver lesion, some studies have shown that small (&#x0003c;1cm) hepatic lesions are more likely to be benign even in patients with a cancer diagnosis [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. While metastases may be a common diagnosis in cancer, it is important to recognise varied patterns of liver metastases after chemotherapy or after surgery. Chemotherapy-related focal or nodular fat deposition can also lead to variety of pseudolesions and one needs to be aware of these appearances and distinguish them from fat-containing hepatic tumors [<xref ref-type="bibr" rid="B3">3</xref>]. Uncommon occurrence of hepatic peliosis and sinusoidal obstruction syndrome also needs to be kept in mind in patients with cancer [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>In patients with chronic liver disease, ultrasound surveillance is the method of choice for the early detection of HCC in cirrhosis [<xref ref-type="bibr" rid="B5">5</xref>]. For characterization of focal lesions in cirrhosis, EASL-EORTC and AASLD recommend multi-phasic contrast-enhanced MDCT or MRI. Imaging features typical for HCC is arterial phase hypervascularity and wash-out to hypoattenuation/hypointensity in the venous and/or equilibrium phase, which allows non-invasive diagnosis of HCC [<xref ref-type="bibr" rid="B6">6</xref>]. Recently diffusion-weighted imaging (DWI) and liver-specific MR contrast agent have been introduced in the clinical routine for detection and lesion characterization. The combination of DWI and liver-specific contrast agents yields the bests results in the detection liver metastases [<xref ref-type="bibr" rid="B7">7</xref>]. For characterization of focal lesions in cirrhosis, administration of liver-specific MR contrast agents may help a make a confident diagnosis [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>].</p><p>In this workshop the work-up of focal liver lesions will be discussed and the varied imaging features of common and less common focal lesions will be presented.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>LH</given-names></name><name><surname>Gandras</surname><given-names>EJ</given-names></name><name><surname>Colangelo</surname><given-names>SM</given-names></name><etal/><article-title>Prevalence and importance of small hepatic lesions found at CT in patients with cancer</article-title><source>Radiology</source><year>1999</year><volume>210</volume><fpage>71</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1148/radiology.210.1.r99ja0371</pub-id><pub-id pub-id-type="pmid">9885589</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Noone</surname><given-names>TC</given-names></name><name><surname>Semelka</surname><given-names>RC</given-names></name><name><surname>Cem Balci</surname><given-names>N</given-names></name><name><surname>Graham</surname><given-names>ML</given-names></name><article-title>Common occurrence of benign liver lesions inpatients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases</article-title><source>J Magn Reson Imaging</source><year>1999</year><volume>10</volume><fpage>165</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1522-2586(199908)10:2&#x0003c;165::AID-JMRI9&#x0003e;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">10441020</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Valls</surname><given-names>C</given-names></name><name><surname>Iannacconne</surname><given-names>R</given-names></name><name><surname>Alba</surname><given-names>E</given-names></name><etal/><article-title>Fat in the liver: diagnosis and characterization</article-title><source>Eur Radiol</source><year>2006</year><volume>16</volume><fpage>2292</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1007/s00330-006-0146-0</pub-id><pub-id pub-id-type="pmid">16477402</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Iannaccone</surname><given-names>R</given-names></name><name><surname>Federle</surname><given-names>MP</given-names></name><name><surname>Brancatelli</surname><given-names>G</given-names></name><etal/><article-title>Peliosis hepatis: spectrum of imaging findings</article-title><source>AJR Am J Roentgenol</source><year>2006</year><volume>187</volume><fpage>W43</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.2214/AJR.05.0167</pub-id><pub-id pub-id-type="pmid">16794138</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Forner</surname><given-names>A</given-names></name><name><surname>Llovet</surname><given-names>JM</given-names></name><name><surname>Bruix</surname><given-names>J</given-names></name><article-title>Hepatocellular carcinoma</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>1245</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)61347-0</pub-id><pub-id pub-id-type="pmid">22353262</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><collab>European Association For The Study Of The Liver</collab><collab>European Organisation For Research And Treatment Of Cancer</collab><article-title>EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma</article-title><source>J Hepatol</source><year>2012</year><volume>56</volume><fpage>908</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">22424438</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>L&#x000f6;wenthal</surname><given-names>D</given-names></name><name><surname>Zeile</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>WY</given-names></name><etal/><article-title>Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging</article-title><source>Eur Radiol</source><year>2011</year><volume>21</volume><fpage>832</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1007/s00330-010-1977-2</pub-id><pub-id pub-id-type="pmid">20886339</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>HJ</given-names></name><name><surname>Byun</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><etal/><article-title>Differentiation of small (&#x02264;2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images</article-title><source>Abdom Imaging</source><year>2015</year><volume>40</volume><fpage>64</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s00261-014-0188-8</pub-id><pub-id pub-id-type="pmid">24997560</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>MJ</given-names></name><name><surname>Park</surname><given-names>CK</given-names></name><name><surname>Rhim</surname><given-names>H</given-names></name><article-title>Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease</article-title><source>AJR Am J Roentgenol</source><year>2011</year><volume>197</volume><fpage>W868</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.2214/AJR.10.6237</pub-id><pub-id pub-id-type="pmid">22021534</pub-id></mixed-citation></ref></ref-list></back></article>